Medicines, 2022
Shortlist up to four to read them side by side.
1,349 medicine recalls FDA’s Enforcement Report published in 2022, newest first; 18,075 in all since 2012.
FDA’s medicine recalls, as its Enforcement Report classifies them, from June 2012. Lists of FDA’s records can’t be saved for alerts: openFDA asks that its data not be used to alert the public (openFDA); FDA’s own emails do that. Copied Nov 6, 2026.
1,349of 1,349 medicine recallsshown with your filters
The list
- Medicine recall Open Nature Cough Drops Menthol-Cough Suppressant/Oral Anesthetic Peppermint Naturally Flavored Subpotent drug: Low OOS for menthol content at the three month room temperature. Class IIIFDA’s classMay 25, 2022in FDA’s Enforcement Report4 statesnamed in where it went PublishedMay 25, 2022ClassClass IIIStatusTerminatedWhereCalifornia, Idaho, Oklahoma and Pennsylvania
- Medicine recall Nitrofurantoin Capsules, USP (Monohydrate/Macrocrystals), 100 mg, 100 Capsules Failed Dissolution Specifications: Nitrofurantoin Capsules recalled due to dissolution failure at 0-time of the repackaged lot. Class IIIFDA’s classMay 25, 2022in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedMay 25, 2022ClassClass IIIStatusTerminatedWhereNationwide
- Medicine recall Sirolimus Oral Solution, 1 mg/mL, 60 mL bottle Failed Dissolution Specifications: Sirolimus Oral Solution recalled due to lot RZ1598 exceeded the specification limit at the 14-month timepoint. Class IIIFDA’s classMay 25, 2022in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedMay 25, 2022ClassClass IIIStatusTerminatedWhereNationwide
- Medicine recall Humalog KwikPen, Insulin lispro injection, U-100, 100 units per mL, 5x3 mL Prefilled Pens per box TEMPERATURE ABUSE: Products were exposed to temperatures outside of the products labeled storage conditions due to inclement weather. FDA Class I, its most serious class Class IFDA’s class (needs attention)May 25, 2022in FDA’s Enforcement ReportNew Mexicothe one state its words name PublishedMay 25, 2022ClassClass IStatusCompletedWhereNew Mexico
- Medicine recall Trulicity (dulaglutide) injection, 1.5 mg/0.5mL once weekly, 4 Single-Dose Pens TEMPERATURE ABUSE: Products were exposed to temperatures outside of the products labeled storage conditions due to inclement weather. Class IIFDA’s classMay 25, 2022in FDA’s Enforcement ReportNew Mexicothe one state its words name PublishedMay 25, 2022ClassClass IIStatusCompletedWhereNew Mexico
- Medicine recall Trulicity (dulaglutide) injection, 0.75 mg/0.5mL once weekly, 4 Single-Dose Pens TEMPERATURE ABUSE: Products were exposed to temperatures outside of the products labeled storage conditions Class IIFDA’s classMay 25, 2022in FDA’s Enforcement ReportNew Mexicothe one state its words name PublishedMay 25, 2022ClassClass IIStatusCompletedWhereNew Mexico
- Medicine recall Xanax XR (alprazolam) extended-release tablets, 3 mg, 60-count bottle Failed Dissolution Specifications: low out of specification results for dissolution. Class IIFDA’s classMay 18, 2022in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedMay 18, 2022ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall MVASI (bevacizumab-awwb), Injection, For Intravenous Infusion After Dilution, 100 mg/4 ml, Single dose vial Defective container: loose crimp defect, potential loss of container integrity. Class IIFDA’s classMay 18, 2022in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedMay 18, 2022ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall SyrSpend SF Suspending Base, Cherry Flavored Microbial Contamination of Non-Sterile Product: Product is contaminated with Burkholderia gladioli. FDA Class I, its most serious class Class IFDA’s class (needs attention)May 18, 2022in FDA’s Enforcement ReportNationwideFDA’s word, and 1 state named PublishedMay 18, 2022ClassClass IStatusCompletedWhereNationwide, and Puerto Rico named
- Medicine recall buPROPion Hydrochloride Extended-Release Tablet, USP (SR), 150 mg Presence Of Foreign Substance: Customer complaint for the presence of dark, gritty substance found within the bottle which was determined to be activated… Class IIIFDA’s classMay 18, 2022in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedMay 18, 2022ClassClass IIIStatusTerminatedWhereNationwide
- Medicine recall buPROPion Hydrochloride Extended-Release Tablet, USP (SR), 200 mg, 60-count bottle Presence Of Foreign Substance: Customer complaint for the presence of dark, gritty substance found within the bottle which was determined to be activated… Class IIIFDA’s classMay 18, 2022in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedMay 18, 2022ClassClass IIIStatusTerminatedWhereNationwide
- Medicine recall Kill ‘Dat Sanitizing Products Hand Sanitizer, 1 gallon CGMP Deviations: FDA analysis found product to contain acetaldehyde above specification limits. Class IIFDA’s classMay 18, 2022in FDA’s Enforcement ReportLouisianathe one state its words name PublishedMay 18, 2022ClassClass IIStatusTerminatedWhereLouisiana
- Medicine recall Esomeprazole Magnesium Delayed-Release Capsules, USP 20 mg Failed Impurities/Degradation Specifications: OOS result was obtained for Any Other Individual Impurity at the 12M room temperature time point. Class IIFDA’s classMay 18, 2022in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedMay 18, 2022ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Esomeprazole Magnesium Delayed-Release Capsules, USP 40 mg Failed Impurities/Degradation Specifications: OOS result was obtained for Any Other Individual Impurity at the 12M room temperature time point. Class IIFDA’s classMay 18, 2022in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedMay 18, 2022ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Nandrolone Decanoate, USP, 100 g per plastic container Subpotent Drug Class IIIFDA’s classMay 18, 2022in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedMay 18, 2022ClassClass IIIStatusTerminatedWhereNationwide
- Medicine recall Nandrolone Decanoate, USP, 500 g per plastic container Subpotent Drug Class IIIFDA’s classMay 18, 2022in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedMay 18, 2022ClassClass IIIStatusTerminatedWhereNationwide
- Medicine recall Nandrolone Decanoate, USP, 1 kg per plastic container Subpotent Drug Class IIIFDA’s classMay 18, 2022in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedMay 18, 2022ClassClass IIIStatusTerminatedWhereNationwide
- Medicine recall Nandrolone Decanoate, USP, 500 g per plastic container Subpotent Drug Class IIIFDA’s classMay 18, 2022in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedMay 18, 2022ClassClass IIIStatusTerminatedWhereNationwide
- Medicine recall Nandrolone Decanoate, USP, 1 kg per plastic container Subpotent Drug Class IIIFDA’s classMay 18, 2022in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedMay 18, 2022ClassClass IIIStatusTerminatedWhereNationwide
- Medicine recall Norepinephrine 8mg CGMP Deviations Class IIFDA’s classMay 11, 2022in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedMay 11, 2022ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Fentanyl 2mcg/ml and Bupivacaine 0.125% CGMP Deviations Class IIFDA’s classMay 11, 2022in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedMay 11, 2022ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Vancomycin HCl 1.5 g CGMP Deviations Class IIFDA’s classMay 11, 2022in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedMay 11, 2022ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Losartan Potassium Tablets, USP, 25 mg, a) 90-count bottles (NDC # 33342-044-10), b) 1000-count bottles (NDC… CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits Class IIFDA’s classMay 11, 2022in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedMay 11, 2022ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Losartan Potassium Tablets, USP, 50 mg, a) 30-count bottles (NDC # 33342-045-07), b) 90-count bottles (NDC #… CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits Class IIFDA’s classMay 11, 2022in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedMay 11, 2022ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Losartan Potassium Tablets, USP, 100 mg, a) 30-count bottles (NDC # 33342-046-07), b) 90-count bottles (NDC #… CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits Class IIFDA’s classMay 11, 2022in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedMay 11, 2022ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Losartan Potassium & Hydrochlorothiazide Tablets, USP, 50 mg/12.5 mg, a) 30-count bottles (NDC#… CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits Class IIFDA’s classMay 11, 2022in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedMay 11, 2022ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Losartan Potassium & Hydrochlorothiazide Tablets, USP, 100 mg/25 mg, a) 30-count bottles (NDC# 33342-052-07),… CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits Class IIFDA’s classMay 11, 2022in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedMay 11, 2022ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Losartan Potassium & Hydrochlorothiazide Tablets, USP, 100 mg/12.5 mg, a) 30-count bottles (NDC#… CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits Class IIFDA’s classMay 11, 2022in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedMay 11, 2022ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Losartan Potassium Tablets USP, 25 mg, a) 90-count bottles (NDC# 68180-376-03), b) 1000-count bottles (NDC#… CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits Class IIFDA’s classMay 11, 2022in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedMay 11, 2022ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Losartan Potassium Tablets USP, 50 mg, a) 90-count bottles (NDC# 68180-377-03), b) 1000-count bottles (NDC#… CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits Class IIFDA’s classMay 11, 2022in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedMay 11, 2022ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Losartan Potassium Tablets USP, 100 mg, a) 90-count bottles (NDC# 68180-378-03), b) 1000-count bottles (NDC#… CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits Class IIFDA’s classMay 11, 2022in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedMay 11, 2022ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Losartan Potassium and Hydrochlorothiazide Tablets USP, 50 mg/12.5 mg a) 30-count bottles (NDC# 68180-215-06)… CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits Class IIFDA’s classMay 11, 2022in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedMay 11, 2022ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Losartan Potassium and Hydrochlorothiazide Tablets USP, 100 mg/25 mg a) 30-count bottles (NDC# 68180-217-06)… CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits Class IIFDA’s classMay 11, 2022in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedMay 11, 2022ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Losartan Potassium and Hydrochlorothiazide Tablets USP, 100 mg/12.5 mg a) 30-count bottles (NDC#… CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits Class IIFDA’s classMay 11, 2022in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedMay 11, 2022ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall alprazolam XR extended-release tablets, 3 mg, 60-count bottle Failed Dissolution Specifications: low out-of-specification dissolution test results observed. Class IIFDA’s classMay 11, 2022in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedMay 11, 2022ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Lidocaine Hydrochloride Oral Topical Solution, USP (Viscous) 2%, 100 mL per bottle Failed viscosity specification - product was below specificcation Class IIIFDA’s classMay 11, 2022in FDA’s Enforcement ReportNationwideFDA’s word, and 1 state named PublishedMay 11, 2022ClassClass IIIStatusTerminatedWhereNationwide, and Puerto Rico named
- Medicine recall Halobetasol Propionate Ointment 0.05% CGMP Deviations: all products within expiry are being recalled because the manufacturing firm, Teligent Pharma, Inc.is discontinuing its stability study… Class IIFDA’s classMay 11, 2022in FDA’s Enforcement ReportNationwideFDA’s word, and 2 states named PublishedMay 11, 2022ClassClass IIStatusOngoingWhereNationwide, and Guam and Northern Mariana Islands named
- Medicine recall Lidocaine Hydrochloride Topical Solution USP 4% CGMP Deviations: all products within expiry are being recalled because the manufacturing firm, Teligent Pharma, Inc.is discontinuing its stability study… Class IIFDA’s classMay 11, 2022in FDA’s Enforcement ReportNationwideFDA’s word, and 2 states named PublishedMay 11, 2022ClassClass IIStatusOngoingWhereNationwide, and Guam and Northern Mariana Islands named
- Medicine recall Lidocaine Prilocaine Cream USP, 2.5%/2.5% CGMP Deviations: all products within expiry are being recalled because the manufacturing firm, Teligent Pharma, Inc.is discontinuing its stability study… Class IIFDA’s classMay 11, 2022in FDA’s Enforcement ReportNationwideFDA’s word, and 2 states named PublishedMay 11, 2022ClassClass IIStatusOngoingWhereNationwide, and Guam and Northern Mariana Islands named
- Medicine recall Betamethasone Dipropionate Ointment USP, 0.05%* (Augmented) (Potency expressed as betamethasone), 15 gram tube CGMP Deviations: all products within expiry are being recalled because the manufacturing firm, Teligent Pharma, Inc.is discontinuing its stability study… Class IIFDA’s classMay 11, 2022in FDA’s Enforcement ReportNationwideFDA’s word, and 2 states named PublishedMay 11, 2022ClassClass IIStatusOngoingWhereNationwide, and Guam and Northern Mariana Islands named
- Medicine recall Erythromycin Topical Gel USP, 2% CGMP Deviations: all products within expiry are being recalled because the manufacturing firm, Teligent Pharma, Inc.is discontinuing its stability study… Class IIFDA’s classMay 11, 2022in FDA’s Enforcement ReportNationwideFDA’s word, and 2 states named PublishedMay 11, 2022ClassClass IIStatusOngoingWhereNationwide, and Guam and Northern Mariana Islands named
- Medicine recall Pantoprazole Sodium Delayed-Release Tablets, USP, 20 mg CGMP deviations: tablets cracking Class IIFDA’s classMay 11, 2022in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedMay 11, 2022ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Lansoprazole Delayed-Release Orally Disintegrating Tablets, 30 mg, 10 Packs of 10 Tablets each, 100 Tablets… Failed Dissolution Specifications Class IIFDA’s classMay 11, 2022in FDA’s Enforcement ReportOhiothe one state its words name PublishedMay 11, 2022ClassClass IIStatusTerminatedWhereOhio
- Medicine recall Mickey Mouse Hand Sanitizer, ethyl alcohol 68%, 2.11 oz./to mL bottle, Best Brands Consumer Products, Inc.,… Chemical Contamination; FDA analysis found product to contain methanol FDA Class I, its most serious class Class IFDA’s class (needs attention)May 11, 2022in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedMay 11, 2022ClassClass IStatusTerminatedWhereNationwide
- Medicine recall The Mandalorian Hand Sanitizer, ethyl alcohol 68%, 2.11 oz./60 mL bottles, Best Brands Consumer Products,… Chemical Contamination; FDA analysis found product to contain benzene FDA Class I, its most serious class Class IFDA’s class (needs attention)May 11, 2022in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedMay 11, 2022ClassClass IStatusTerminatedWhereNationwide
- Medicine recall Suave 24-Hour Protection Aerosol Antiperspirant Powder scent, Aluminum Chlorohydrate Chemical contamination: presence of benzene FDA Class I, its most serious class Class IFDA’s class (needs attention)May 4, 2022in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedMay 4, 2022ClassClass IStatusOngoingWhereNationwide
- Medicine recall Suave 24-Hour Protection Aerosol Antiperspirant Fresh scent, Aluminum Chlorohydrate CGMP Deviation; manufactured at the same facility where other lots were found to be contaminated with benzene Class IIFDA’s classMay 4, 2022in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedMay 4, 2022ClassClass IIStatusOngoingWhereNationwide
- Medicine recall TORCO RACING FUELS HAND SANITIZER, Alcohol Antiseptic 80% Topical Solution, Hand Sanitizer Non-Sterile… CGMP Deviations: FDA analysis found product to contain acetaldehyde and acetal above specification limits. Class IIFDA’s classMay 4, 2022in FDA’s Enforcement ReportNot namedno state, in where it went PublishedMay 4, 2022ClassClass IIStatusTerminatedWhereNo state named
Nothing matches all of these.
Remove a filter to see more. Each one is a fact FDA’s record publishes, so a recall can be left out because its record is silent on it.
Source:
FDA, Drug recall enforcement reports. Released Nov 3, 2026. Updated weekly.
Recalls of food, medicines, medical devices, pet food and animal drugs are from the U.S. Food and Drug Administration (FDA). FDA does not endorse Hearth Record. openFDA: “Do not rely on openFDA to make decisions regarding medical care.”
Your shortlist0 of 4
Add one more to compare.